International Journal of Generic Drugs
Handbook of Generic Drug Development.
http://www.locum.co.il/

International Pharmaceutical Abstracts (IPA)
presents and reviews pharmaceutical literature, which includes clinical and technical drug information, pharmacy practice, pharmaceutical education and the legal aspects of pharmacy and drugs.
http://www.library.ucsf.edu/db/international-pharmaceutical-abstracts-ipa

James Lind Institute (JLI)
An educational division of Clinexa Life Sciences Pvt. Ltd. Clinexa is a Contract Research Organization (CRO) making its mark in niche areas of clinical research.
http://www.jli.edu.in

Januvia - DPP-IV inhibitor for Type 2 Diabetes
Januvia (sitagliptin phosphate) is an antihyperglycaemic drug containing an orally active inhibitor of the dipeptidyl peptidase-IV (DPP-IV) enzyme. Developed by Merck Sharp & Dohme (MSD), a UK subsidiary of Merck & Co, sitagliptin is used for treating typ
http://www.drugdevelopment-technology.com/projects/januvia/

Kardiologie
Kardiologie
http://www.medizinfo.com/schwarz/html/home.htm

Laboratoire Bailly-Creat
CREAT is a French laboratory founded in 1972, and based near PARIS Our specialities : Manufacturing and packaging essentials and generic products. Subcontracting.
http://www.creat-international.com/

Laboratorio Chile Productos
Catálogo de medicamentos de uso humano
http://www.pharmatrade.cl/productos.php

Laboratorios Aseptic
Laboratorios Aseptic interactive web site.
http://pagina.de/aseptic

Lactulose (Duphalac)
Drug card
http://www.pharmacist-development.com/2011/02/lactulose-duphalac-drug-card.html

Lamictal – Approved Treatment for Epilepsy and Bipolar, USA
Lamictal XR (lamotrigine), developed by GlaxoSmithKline, is an approved treatment for epilepsy and bipolar I disease. The drug was first approved by the US Food and Drug Administration (FDA) in 1994. Over the years the drug has been tested and approved as
http://www.drugdevelopment-technology.com/projects/lamictal-by-gsk/

Anterior

11

12

13

14

15

16

17

18

19

Siguiente